
David W Victor III MD
Hepatology & Liver Transplantation
Associate Professor of Clinical Medicine Weill Cornell Medical College Hepatology and Transplant Medicine Houston Methodist Houston, TX
Join to view full profile
18300 Katy FreewaySuite 425Houston, TX 77094
Phone+1 713-441-4345
Fax+1 713-790-3089
Dr. Victor is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Transplant Hepatology, 2012 - 2013
Tulane UniversityFellowship, Gastroenterology, 2008 - 2011
Tulane UniversityResidency, Internal Medicine, 2005 - 2008
University of Kentucky College of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2013 - 2027
MD State Medical License 2011 - 2025
LA State Medical License 2007 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology
Clinical Trials
Publications & Presentations
PubMed
- Developing a fully automated imaging biomarker for HCC risk assessment via MRI-based tumor segmentation and EPM.Awj Twam, Shane A Smith, Mohamed Eltaher, Zaina Boriek, Adrian Celaya
Scientific Reports. 2026-06-10 - 2 citationsDisparities in liver transplantation for metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma.David W Victor, Sudha Kodali, Mazen Noureddin, Elizabeth W Brombosz, Analisa Lopez
World Journal of Transplantation. 2025-09-18 - 11 citationsCefepime-zidebactam therapy for extensively drug-resistantandinfection as a bridge to liver transplantation.Shemual Tsai, Masayuki Nigo, Donghoon Kang, Rodrigo P Baptista, Pranita D Tamma
JAC-Antimicrobial Resistance. 2025-08-01
Press Mentions
Houston Methodist Pioneers Short Sequence MRI to Diagnose Fatty Liver Disease with FibrosisJune 27th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: